DGX Dividend: Quest Diagnostics Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	10,850	9,872	9,252	9,883	10,788	9,437
Revenue Growth (YoY)	14%	7%	-6%	-8%	14%	22%
Cost of Revenue	7,219	6,599	6,186	6,418	6,510	5,834
Gross Profit	3,631	3,273	3,066	3,465	4,278	3,603
Selling, General & Admin	1,909	1,731	1,630	1,818	1,680	1,509
Research & Development	--	--	--	--	--	--
Operating Expenses	2,035	1,865	1,750	1,945	1,781	1,612
Other Non Operating Income (Expenses)	14	12	0	--	369	76
Pretax Income	1,287	1,175	1,130	1,235	2,599	1,884
Income Tax Expense	301	273	248	264	597	460
Net Income	963	866	850	942	1,988	1,425
Net Income Growth	15%	2%	-10%	-53%	40%	67%
Shares Outstanding (Diluted)	113	113	113	118	128	136
Shares Change (YoY)	0%	0%	-4%	-8%	-6%	0%
EPS (Diluted)	8.52	7.66	7.52	7.98	15.53	10.48
EPS Growth	15%	2%	-6%	-49%	48%	67%
Free Cash Flow	1,393	909	864	1,314	1,830	1,587
Free Cash Flow Per Share	12.32	8.04	7.64	11.13	14.29	11.66
Gross Margin	33.46%	33.15%	33.13%	35.06%	39.65%	38.17%
Operating Margin	14.7%	14.26%	14.22%	15.37%	23.14%	21.09%
Profit Margin	8.87%	8.77%	9.18%	9.53%	18.42%	15.1%
Free Cash Flow Margin	12.83%	9.2%	9.33%	13.29%	16.96%	16.81%
EBITDA	2,156	1,535	1,424	1,640	2,600	2,094
EBITDA Margin	19.87%	15.54%	15.39%	16.59%	24.1%	22.18%
D&A For EBITDA	560	127	108	120	103	103
EBIT	1,596	1,408	1,316	1,520	2,497	1,991
EBIT Margin	14.7%	14.26%	14.22%	15.37%	23.14%	21.09%
Effective Tax Rate	23.38%	23.23%	21.94%	21.37%	22.97%	24.41%

Follow-Up Questions











